Pharma industry lauds RBI’s decision to discontinue automatic caution listing
RBI will continue with caution-listing based on case-specific recommendations of the AD bank
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
SV Veeramani
Digital marketing should continue post-COVID-19: Experts
It reduces expenditure, provides targeted better returns
Customs clearances of China consignments begin but industry objects to demurrage charges
Industry to compile nationwide data of imposed demurrages on each pharma company and present it to government authorities with a…
Pharma industry appreciates CBIC’s move to adopts paperless process
The digital adoption is being carried out in a phased manner the first phase of faceless assessment started in Chennai and…
Strategic short term measures needed on the API front: Pharma experts
Experts feel that a multi-pronged strategy comprising both, short term and long term measures, are crucial to deal with the fall…
Pharma MSMEs ask government to extend incentives of PLI scheme
Due to incremental sales and production provisions of the PLI scheme, the MSME sector is not able to avail the desired benefits
Industry welcomes draft New Drugs and Clinical Trials (Amendment) Rules
Recommend measures for more clarity and impact
DoP seeks MHA intervention for uninterrupted pharma ancillary supplies
Due to nationwide lockdown because of Coronavirus (Covid-19), apart from challenges in transportation and availability of…